A systemic approach to improve patients adherence to medications

Similar documents
ESPACOMP PRE CONFERENCE WORKSHOP: Version

Blueprint Integrated Pilot Programs

Liberating the NHS: No decision about me, without me Further consultation on proposals to shared decision-making

Caring for people with multimorbidity in Europe: an overview from the ICARE4EU project

97% 18% 2% self-employed/ freelancer/contractor. 30% part time. 27% Part time

Chapter 1. Scope of Clinical Pharmacy. M.G.Rajanandh, Department of Pharmacy Practice, SRM College of Pharmacy, SRM University.

Clinical Webinar: Integrated Pharmacy

NCL MEDICATION ADHERENCE CAMPAIGN FREQUENTLY ASKED QUESTIONS 2013

Resilience Approach for Medical Residents

Insights into Pharmacist Provided MTM Services-Present and Future

Tackling the problem of obesity: the Dutch approach

Best Practice Guidelines - BPG 9 Managing Medicines in Care Homes

Medication Adherence

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE SCOPE

18 th ANNUAL ESPACOMP MEETING (November 20-22, 2014 in Lausanne, Switzerland)

Strategic overview: NHS system

Introductie praktijonderzoek Developing indicators to measure pharmaceutical care across nations

Medication Therapy Management

Pharmacy in 2020: Director s View

Keenan Pharmacy Care Management (KPCM)

NHS community pharmacy advanced services Briefing for GP practices

The Pharmacist Coalition for Health Reform

Disease State Management Clinics: A Pharmacist Perspective

W e were aware that optimising medication management

Medido, a smart medication dispensing solution, shows high rates of medication adherence and potential to reduce cost of care.

Medication Accuracy at Transitions in Care Let s start!

Disclosures. Learning Objectives 4/26/2017. Impact of a Pilot Ambulatory Care Pharmacist in a Family Practice Clinic

SFHPHARM27 - SQA Unit Code FA2P 04 Undertake an in-process accuracy check of assembled prescribed items prior to the final accuracy check

Tackling the challenge of non-adherence

GPhC response to the Rebalancing Medicines Legislation and Pharmacy Regulation: draft Orders under section 60 of the Health Act 1999 consultation

MEDICATION THERAPY MANAGEMENT. MemberChoice FORMULARY MANAGEMENT MEDICATION THERAPY MANAGEMENT (MTM) SPECIALTY DRUG MANAGEMENT

Transitions of Care. Objectives 1/6/2016. Roman Digilio, PharmD PGY1 Resident West Kendall Baptist Hospital. The author has nothing to disclose.

Safe & Sound: How to Prevent Medication Mishaps. A Family Caregiver Healthcare Education Program. A Who What Where Why When Tool Kit

By: Jacqueline Kayler DeBrew, MSN, RN, CS, Beth E. Barba, PhD, RN, and Anita S. Tesh, EdD, RN

Statement Of. The National Association of Chain Drug Stores. For. U.S. House of Representatives Committee on Ways and Means Subcommittee on Health

Jan Taco te Gussinklo. On behalf of the Dutch Association for ehealth (NVEH), The Netherlands

Care Home support and medicines optimisation: Community Pharmacy National Enhanced Service

Literature review: pharmaceutical services for prisoners

The Merits of a Robot: a Dutch Experience

2018 Medication Therapy Management Program Information

ehealth in caring for people with multimorbidity in European countries

Expanding Your Pharmacist Team

March 3, i. Medication Reconciliation Post Discharge (Part C) (p. 79)

Medicines Optimisation Strategy

Medication Errors in Chemotherapy PORSCHA L. JOHNSON, PHARM.D. CLINICAL PHARMACIST II MEDSTAR WASHINGTON HOSPITAL CENTER SATURDAY, SEPTEMBER 17, 2016

Community Pharmacy Multi-compartment Compliance Aids Audit

CLINICAL AUDIT. The Safe and Effective Use of Warfarin

Provider Information Guide Complex Care and Condition Care Overview

Cumbria Rural Health Forum Alison Marshall 1, Tom Bell 2, J-Lyn Khoo 1

Passport Advantage (HMO SNP) Model of Care Training (Providers)

Transition of Care Practices. Nancy MacDonald, PharmD, BCPS, FASHP Henry Ford Hospital Detroit, MI

A pharmacist s guide to Pharmacy Services compensation

Pharmacovigilance assessor. National Institute of Pharmacy and Nutrition (OGYÉI) (Hungary) Senior hospital Pharmacist

A pilot qualitative study to explore stakeholder opinions regarding prescribing quality indicators

T O G E T H E R W E M A K E A G R E A T T E A M. January 6, 2014

International Pharmaceutical Federation Fédération internationale pharmaceutique. Standards for Quality of Pharmacy Services

JH-CERSI/FDA Workshop Clinical Trials: Assessing Safety and Efficacy for a Diverse Population

Comparison of a clinical pharmacist managed anticoagulation service with routine medical care: impact on clinical outcomes and health care costs

Improving Access in Infusion Therapy

Bringing the Clinical Mindset to the Retail Pharmacist

Driving the value of health care through integration. Kaiser Permanente All Rights Reserved.

Understanding and improving the quality of medication use: Research in Clinical Pharmacy starting from Academia. Anne Spinewine

Clinical Management of patients: The case for Comprehensive Medication Therapy Management Services

Medication Adherence: Strategies for Improving Outcomes

B. Douglas Hoey, RPh, MBA. CEO National Community Pharmacists Association

BEHAVIOUR CHANGE HTA,

CONSULTANT PHARMACIST INSPECTION LAW REVIEW

arizona health net a better decision sm Putting you at the center of everything we do.

FIP STATEMENT OF POLICY Pharmacy: Gateway to Care

Reducing the High Cost of Patient Non-Adherence:

Course Co ordinator: Trudi Aspden BPharm, PhD. Extension 83893

MEDS TO BEDS AND CARE MANAGEMENT MEDICATION ASSESSMENT TOOLKIT: FOR HOSPITAL TEAM AND PHARMACISTS

The added value of pharmacists in the care of frail older patients

Prescribing in primary care

This controlled document shall not be copied in part or whole without the express permission of the author or the author s representative.

The European network evaluation of the PHAR QA framework of competences for...

Community Pharmacy in 2016/17 and beyond

Use of Health Information Technology to Reduce Health Risk

CLINICAL PRACTICE EVALUATION II: CLINICAL SYSTEMS REVIEW

Expanding an innovative Bedside Concierge program

What is MTM? Objectives. MTM: Successfully Engaging Eligible Patients. What is MTM? MTM Background. MTM Examples 09/11/2012

JOB DESCRIPTION. Responsible to: Deputy Director of Pharmacy & Aseptics Accountable Pharmacist

PHARMACY (PHAR) PHAR 534. Foundations III. 1.5 Hour.

PRESCRIPTION FOR HEALTH A COMPREHENSIVE WEB SITE TO HELP YOU IMPROVE PATIENTS MEDICATION ADHERENCE

HIQA s Medication Safety Monitoring Programme in Public Acute Hospitals. One Year Later

NHS Prescription Services CPAF Screening Questionnaire 2018/19

JOB DESCRIPTION LEAD PRACTICE BASED PHARMACIST. Designated GP Practice in Federation area

Quality Medication Use in Aboriginal Communities

Pharmacy Department, Borders General Hospital

NORTHERN IRELAND MEDICINES OPTIMISATION SCALING UP INNOVATION ACROSS EUROPE

JOB DESCRIPTION. BGH Pharmacy

Pharmacist (Palliative Care) December 2014 Page 1

MTM Performance & Impact On Star Ratings 2016 & Beyond - OutcomesMTM Overview

4. Hospital and community pharmacies

Patient Care: Case Study in EHR Implementation. With Help From Monkeys, Mice, and Penguins. Tom Goodwin, MHA MIT Medical Cambridge, MA March 2007

ehealth in the Netherlands Policies, developments and status of cross-enterprise information exchange in Dutch healthcare

Evaluation of Pharmacy Delivery Models

Effective team working to improve diabetes care in older people

Zukunftsperspektiven der Qualitatssicherung in Deutschland

The Search for Best Practice in Medication Reconciliation

Transcription:

A systemic approach to improve patients adherence to medications a Dutch initiative to create sustainable change Presentation for the Espacomp Congress 2009, Bangor, Wales. Marnix P.D. Westein, Phar. D., email: m.westein@winap.nl Royal Dutch Association for the Advancement of Pharmacy (KNMP) Tom Schoen, Senior Policy Advisor, The Federation of Patients and Consumer Organisations in the Netherlands (NPCF)

Overview of the presentation Facts and figures on medication adherence Survey comparing Dutch initiatives Changing our perspective A systemic approach Conclusion

Facts and Figures (1) Discontinuation percentage of chronic pharmacotherapy in the first year after start of the treatment (Netherlands 2002) Chronic Pharmacotherapy forever Report, Pharmo institute, 2002.

Facts and Figures (2) Adherence percentages found in Dutch Studies (2004) Factors related to adherence Report, NIVEL, 2004.

Internet survey of Dutch initiatives to improve adherence (2007) 41 initiatives were reported Examples: Monitoring drug prescriptions Distribution using a Medicationroll Communications checklists SMS reminder services Periodic Medication review Self management courses Patient Healthcare professional ICT Medicine

Internet survey of Dutch initiatives to improve adherence (2007) Comparing different actors different views on the problem different ways of measuring different solutions Results Unclear outcomes No widespread change

Changing our perspective on improving medication adherence Old perspective New perspective

Changing our perspective (2) Medication adherence is influenced by many variables which are highly interconnected many actors who act partly independent and act on multiple levels This generates outcomes which are difficult to measure and difficult to predict. In Health promotion research such a system is referred to as a complex or soft system.

A systemic approach is needed to create sustainable change Step 1: Investigate the problem Step 2: Develop a rich picture (of the actors, levels and their connections) Step 3: Extract main themes Step 4: Increase cooperation between actors Step 5: Develop and test potential solutions Step 6: Change practice D G Cramp, et al. Health Serv Man Res 2009; 22: 71-80 Naaldenberg J, et al. Glob Health Prom 2009; 16; 39

Step 2: develop a rich picture (NPCF, 2008) Umbrella Organizations Pharm., Phys. and nurses Insurance companies Government Patient organizations Health care environment Nurse Pharmacist Physician ICT Pharmaceutical Companies Research & education Patient Medicine Social environment

Step 3: extract main themes (NPCF, 2008) 1. Improve communication between patients and healthcare professionals 2. Improve cooperation and information sharing between healthcare professionals 3. Develop and prescribe medicines which are easily adapted to patients daily routines 4. Tailor patients support to suit individual needs Tijd voor een beter gebruik van medicijnen, Westein NPCF 2008.

Step 4: Increase cooperation between actors Start of a national taskforce with members from 13 national organizations (KNMP/NPCF 2009) Task: to share visions on improving adherence and debate structure, meaning and power relations To improve cooperation and information sharing To identify and solve practical issues Result 2009: an overview of members activities in 2009 and plans for 2010

Examples of activities 2009 Outlines for a National research program on effective use of medicine Development of multidisciplinary healthcare guidelines for chronic diseases (e.g. diabetes, COPD) Increased pharmacy drug prescription monitoring Increased use of medicationroll Introduction of a yearly medication review for elderly Introduction of prescribing nurses

Step 5: Develop and test potential solutions (2010 ) Quantify goals Set priorities Standardize tools for measurement Develop and pilot interventions Measure results Integrate ICT-tools Increase evidence based practice

Systemic approach: conclusion 2009 2007 Introduction to Pharmionics Vrijens & Urquhart, 2005 Journal of Antimicrobiol Chemotherapy

Initiatives on multiple levels MACRO Health policy MESO Center MICRO Patient-provider dyads PATIENT (De Geest et al., BRIGHT study protocol; McLeroy KR, Bibeau D, Steckler A, Glanz K. An ecological perspective on health promotion programs. Health Educ Q 1988;15(4):351-77.)